ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arkansas » Interventional Cardiology

Top Interventional Cardiology Prescribers in Arkansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOEL CARVER M.D.

Interventional Cardiology

16,519

$684K

1107
900 are 65+

1%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $49

L. NORRIS M.D.

Interventional Cardiology

14,168

$641K

1040
899 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $49

LEON BLUE M.D.

Interventional Cardiology

11,529

$597K

681
554 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $49

ANDRE NOLEWAJKA MD; M.CL.SC

Interventional Cardiology

11,381

$508K

635
536 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $49

FREDERICK HEINEMANN M.D.

Interventional Cardiology

10,229

$653K

845
713 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $49

JEFFREY TAUTH M.D.

Interventional Cardiology

9,169

$444K

970
785 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $49

BARRY TEDDER M.D.

Interventional Cardiology

8,621

$515K

731
532 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $49

MICHAEL GREEN M.D.

Interventional Cardiology

8,490

$448K

796
654 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $49

STANLEY JOSEF M.D.

Interventional Cardiology

8,398

$369K

754
685 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $49

DONALD STEELY M.D.

Interventional Cardiology

8,181

$462K

767
636 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $49

ROGER HILL M.D.

Interventional Cardiology

7,567

$392K

790
606 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $49

JOHN MEHL MD

Interventional Cardiology

7,514

$318K

430
355 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $49

GREGORY ST. JOHN M.D.

Interventional Cardiology

7,166

$327K

754
650 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $49

AMMAR AL-HALLAK M.D.

Interventional Cardiology

6,601

$274K

666
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $49

JAMON PRUITT M.D.

Interventional Cardiology

6,409

$273K

455
372 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $49

JOHN MCKEE M.D.

Interventional Cardiology

6,341

$342K

577
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $49

TED FISH M.D.

Interventional Cardiology

5,772

$274K

469
397 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $49

DAVID CHURCHILL

Interventional Cardiology

5,642

$244K

540
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $49

ALLAN HATCH MD

Interventional Cardiology

5,340

$195K

290
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $49

LEE DAVIS MD

Interventional Cardiology

4,874

$211K

406
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$43
Average prescription price

Avg: $49

DONALD VOELKER MD

Interventional Cardiology

4,199

$256K

369
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $49

CHRISTOPHER SIMPSON MD

Interventional Cardiology

4,031

$216K

411
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $49

VASILI LENDEL MD

Interventional Cardiology

3,969

$284K

670
539 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $49

GEETHA RAMASWAMY M.D.

Interventional Cardiology

3,081

$169K

391
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $49

JOSE LOYO-MOLINA MD

Interventional Cardiology

3,050

$143K

385
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $49

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank